Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients

Antonio Alcaraz(Hospital Clínic de Barcelona)

Scientific Reports

September 29, 2021

10.1038/s41598-021-98586-5

Cited by 15

Related Papers

Prognostic Gene Expression-Based Signature in Clear-Cell Renal Cell Carcinoma

|Cancers|2022|37

Studies on the formation of octopamine in mice and rats

|Biochimica et Biophysica Acta (BBA) - General Subjects|1964|8

Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study

|Journal of Clinical Medicine|2022|7

Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study

|Journal of Clinical Medicine|2022|6